DURSUN, N. Et Al. 2018. Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation. 12 th ISPRM World Congress , (Paris, France), 317.

DURSUN, N., AKARSU, M., Akyuz, M., GÖKBEL, T., KARACAN, Ç., & DURSUN, E., (2018). Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation . 12 th ISPRM World Congress (pp.317). Paris, France

DURSUN, NİGAR Et Al. "Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation," 12 th ISPRM World Congress, Paris, France, 2018

DURSUN, NİGAR Et Al. "Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation." 12 th ISPRM World Congress , Paris, France, pp.317, 2018

DURSUN, N. Et Al. (2018) . "Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation." 12 th ISPRM World Congress , Paris, France, p.317.

@conferencepaper{conferencepaper, author={NİGAR DURSUN Et Al. }, title={Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation}, congress name={12 th ISPRM World Congress}, city={Paris}, country={France}, year={2018}, pages={317} }